Peter Heenan

Peter Heenan is a Clinical Professor at the University of Western Australia (UWA), affiliated with the UWA Medical School and the Department of Pathology & Laboratory Medicine. His research focuses on melanoma, oncology, and dermatological pathology, with a particular emphasis on tumor recurrence, biomarkers, and diagnostic techniques. He has contributed to studies on sentinel lymph node biopsies, circulating tumor cells, and surgical margin accuracy in melanoma patients.

His expertise aligns with UN Sustainable Development Goals related to health and well-being. Notable projects include a Phase II clinical trial evaluating tea tree oil for actinic keratosis, funded by the NHMRC. Despite no explicitly listed awards, his work has garnered significant citations, reflecting its impact in melanoma research.

Research interests span melanoma prognosis, recurrence mechanisms, and molecular markers. His articles analyze diagnostic accuracy, recurrence prediction, and therapeutic targets, contributing to advancements in oncology and pathology practices.